Finoriq research workspace
NOVO NORDISK A S (NVO) Historical Metrics
Novo Nordisk A/S engages in the research and development, manufacture, and distribution of. Review NVO fundamentals, ratios, and historical filing metrics on Finoriq.
Company Snapshot
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
- Company
- NOVO NORDISK A S (NVO)
- Ticker
- NVO
- Market Cap
- $219.9B
- Latest Price
- $49.67
- Industry
- Biotech & Pharma
NOVO NORDISK A S (NVO) Current Valuation Metrics
Static valuation preview for NOVO NORDISK A S (NVO). Market data retrieved 2026-06-17. Filing currency DKK.
| Metric | Value | Source |
|---|---|---|
| P/EMarket cap divided by latest TTM net income. | 12.2x | Net Income | TTM FY 2025 |
| P/SMarket cap divided by latest TTM revenue. | 4.06x | Revenue | TTM FY 2025 |
| P/Operating Cash FlowMarket cap divided by latest TTM operating cash flow. | 10.5x | Operating Cash Flow | TTM FY 2025 |
| Earnings YieldLatest TTM net income divided by market cap. | 8.2% | Net Income | TTM FY 2025 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | 9.5% | Operating Cash Flow | TTM FY 2025 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.